July 2016

Patients with lung cancer who participated in a Web-based system for reporting and tracking their symptoms achieved dramatic gains in survival compared with individuals who were followed with typical protocols, according to a study presented at the annual meeting of the American Society of Clinical Oncology.

The Targeted Agent and Profiling Utilization Registry (TAPUR) study has added its seventh and eighth pharmaceutical companies, Bayer and Merck, and 30 additional trial participants.

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo